AI for Drug Discovery

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instanceOf gptkb:Research_Institute
gptkbp:aimsTo Patient Safety
Clinical Decision Making
Collaboration between Sectors
Research Efficiency
Target Identification
Drug Repurposing
Molecular Docking
Data_Integration
Healthcare_Delivery
Patient_Outcomes
gptkbp:appliesTo Pharmaceutical_Research
gptkbp:associated_with Big_Data
gptkbp:collaborations Data_Scientists_and_Pharmacologists
gptkbp:competitors Healthcare
gptkbp:enhances Predictive Modeling
gptkbp:facilitates Personalized Medicine
Global_Health_Initiatives
gptkbp:features Computational Biology
gptkbp:has_a_focus_on Research_and_Development
Venture_Capital_Investment
gptkbp:hasPrograms Cost-Effective_Solutions
https://www.w3.org/2000/01/rdf-schema#label AI for Drug Discovery
gptkbp:improves Drug_Design
gptkbp:includes Clinical Trial Design
Toxicology Studies
Patient Stratification
Biomarker_Discovery
gptkbp:influenced Artificial Intelligence
Neural Networks
gptkbp:involves Data Mining
gptkbp:is_a_key_component_of Drug Development Process
gptkbp:is_a_subject_of Ethical Considerations
Patent Applications
gptkbp:is_a_time_for Data-Driven_Drug_Development
gptkbp:is_a_tool_for Healthcare_Professionals
gptkbp:is_part_of gptkb:Digital_Health
Precision Medicine
Innovation in Medicine
Future of Medicine
gptkbp:is_studied_in Academic Institutions
Clinical_Data
gptkbp:is_used_in Genomics
Proteomics
Pharmaceutical Companies
Virtual Screening
gptkbp:leads Novel Therapies
Faster Approvals
Innovative_Drug_Formulations
gptkbp:mayHave Chemical Structures
gptkbp:notable_event Drug Interactions
gptkbp:performance Lead Compounds
gptkbp:provides Real-time Insights
gptkbp:reduces Time to Market
Development Costs
gptkbp:streamingPlatforms Regulatory Processes
gptkbp:supports Clinical Trials
gptkbp:surrounding_area Pharmaceutical Innovation
gptkbp:uses Deep Learning
Machine Learning
gptkbp:utilizes Bioinformatics
gptkbp:visitedBy Drug Candidates